Literature DB >> 16213

Fate of orally ingested enzymes in pancreatic insufficiency. Comparison of two dosage schedules.

E P DiMagno, J R Malagelada, V L Go, C G Moertel.   

Abstract

To assess the fate and efficacy of orally ingested enzymes in pancreatic insufficiency, we administered pancreatin to six patients by two schedules--eight tablets with a standard meal or two tablets hourly--and in six normal controls, quantified duodenal enzyme activity and related inactiviation of ingested enzymes to gastric and duodenal pH; in the six patients we measured malabsorption by fecal balance studies. Postprandially, gastric pH was similar in health and pancreatic insufficiency, and below 4 after 40 minutes. Duodenal pH in pancreatic insufficiency declined to approximately 4 beyond 100 minutes--lower than in health (P less than 0.05). Approximately 22 per cent and 8 per cent of trypsin and lipase activity ingested with either schedule was delivered to the ligament of Treitz. Prandial was as effective as hourly administration in decreasing steatorrhea and perhaps more effective in abolishing azotorrhea, and since it is also more convenient, we recommend it.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 16213     DOI: 10.1056/NEJM197706092962304

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  65 in total

1.  Postcibal gastric emptying of pancreatin pellets: effects of dose and meal oil.

Authors:  J H Meyer; R Lake; J D Elashoff
Journal:  Dig Dis Sci       Date:  2001-09       Impact factor: 3.199

Review 2.  Pancreatic enzyme replacement therapy.

Authors:  P Layer; J Keller; P G Lankisch
Journal:  Curr Gastroenterol Rep       Date:  2001-04

Review 3.  Enzyme contents of pancreatic extract preparations. Are they optimal?

Authors:  S Maguire; M C Goodchild
Journal:  Drugs       Date:  1992-11       Impact factor: 9.546

4.  Monitoring enzyme replacement treatment in exocrine pancreatic insufficiency using the cholesteryl octanoate breath test.

Authors:  S Mundlos; P Kühnelt; G Adler
Journal:  Gut       Date:  1990-11       Impact factor: 23.059

Review 5.  Human pancreatic exocrine response to nutrients in health and disease.

Authors:  J Keller; P Layer
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

Review 6.  Uses and abuses of enzyme therapy in cystic fibrosis.

Authors:  P Durie; D Kalnins; L Ellis
Journal:  J R Soc Med       Date:  1998       Impact factor: 5.344

7.  Two enteric coated microspheres in cystic fibrosis.

Authors:  J Williams; A MacDonald; P H Weller; J Fields; H Pandov
Journal:  Arch Dis Child       Date:  1990-06       Impact factor: 3.791

8.  Impairment of folic acid absorption by oral pancreatic extracts.

Authors:  R M Russell; S K Dutta; E V Oaks; I H Rosenberg; A C Giovetti
Journal:  Dig Dis Sci       Date:  1980-05       Impact factor: 3.199

9.  Conjugated bile acids in serum and secretions in response to cholecystokinin/secretin stimulation in children with cystic fibrosis.

Authors:  T A Robb; G P Davidson; C Kirubakaran
Journal:  Gut       Date:  1985-11       Impact factor: 23.059

Review 10.  Pancreatic enzymes in chronic pancreatitis.

Authors:  P Layer; G Holtmann
Journal:  Int J Pancreatol       Date:  1994-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.